Abstract: The present disclosure relates to a method of altering intestinal microbiome in a patient having cystic fibrosis comprising administering at least one of Bifidobacterium and/or Bacteroides to a patient and allowing the Bifidobacterium and/or Bacteroides to alter the intestinal microbiome.
Type:
Grant
Filed:
March 26, 2019
Date of Patent:
June 7, 2022
Assignees:
Trastees of Dartmouth College, Dartmouth-Hitchcock Clime